Diabetes Market Analysis, Size, Trends | United States | 2019-2025 | MedSuite (Includes 9 Reports)

  • Year: 2019
  • Scope: 2015-2025
  • Region: United States
  • Pages: 287
  • Published Date: 06/04/2019
  • Type: MedSuite

In 2018, the fastest-growing segment in the diabetes care market was the FGM market, which increased dramatically in value. The high level of growth was attributed to the commercial launch of FGM in late 2017. Abbott received FDA approval for FreeStyle® Libre in September 2017 and for FreeStyle® Libre 14 Day in July 2018. The FGM market has experienced significant growth in international markets since it was first commercially launched in Europe in 2014. Growth in the

The value of the durable pump market increased significantly in 2018, which was primarily attributed to the strong sales performance from both Medtronic and Tandem’s latest product offerings and Animas exiting the market. In October 2017, Animas announced that it was closing operations and exiting the insulin pump market, which forced its large installed base of users to switch pumps in 2018. Animas selected Medtronic as its partner of choice to offer a smooth transition for patients that wanted to transfer to a Medtronic pump.

Major Segments Covered in the Diabetes  Market Report Suite

While this report suite contains all U.S. diabetes device data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the diabetes device market research that you need. You can view all these included reports and segmentation here:

  • US Procedure Numbers for Diabetes Monitoring, Treatment and Drug Delivery 2019 – MedPro: Using a number of databases, internal and external, we’re able to provide you with the total volume of diabetes procedures being performed for each of the markets mentioned in this suite of reports.
  • US Market Report for Blood Glucose Meters 2019 – MedCore:Blood glucose meters are electronic devices that analyze a small drop of blood drawn using a lancet and lancing device. The blood is placed on a small disposable test strip that is inserted into the blood glucose meter, which reads the level of glucose in the blood. The blood glucose meter is battery-powered and fits in the palm of the hand. When the blood is placed on the strip, it flows in through capillary action. The electrochemical reaction between the test strip and the blood determines the blood glucose concentration reported as milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L).
  • US Market Report for Blood Glucose Test Strips 2019 – MedCore: Blood glucose test strips are thin strips with enzymes that react to blood droplets. These create either a photometric or electrochemical response which is read by a glucose meter. Strips vary by size, chemical makeup, fluid channels, etc. and are typically sold in containers of 50 or 100. A single strip is used for each test, and some brands have preloaded strip storage within their meters.
  • US Market Report for Lancet and Lancing Devices 2019 – MedCore: A lancet is a small needle with a plastic or rubber coating that fits into the top of a lancing device. Lancing devices are pen-like instruments which are used in conjunction with a lancet to draw blood to be applied to a glucose strip. Many lancets come as a component of blood glucose monitoring kits, and can be adjusted for injection depth. Reusable lancets are not as effective as they are more dull and painful and increase the risk of infection.
  • US Market Report for Continuous Glucose Monitoring 2019 – MedCore: Continuous glucose monitoring (CGM) allows for a more accurate reading of how blood glucose levels fluctuate throughout the day by measuring interstitial glucose levels on a continuous basis and estimating blood glucose levels based on these readings.
  • US Market Report for Insulin 2019 – MedCore: Insulin is a hormone that causes glucose uptake from the blood through the cells of the liver, muscle and fat tissue to be stored as glycogen in the liver and muscle. Type 1 diabetics’ immune systems destroy pancreatic beta cells: the only cells that can make insulin. The body therefore fails to produce insulin and cannot naturally convert food into energy. Type 2 diabetics have a resistance to insulin, and cells are not able to use the insulin present in the body. The need for insulin increases to the point that the pancreas can no longer produce it. Insulin is therefore a mode of treating both type 1 and type 2 diabetes.
  • US Market Report for Insulin Pen 2019 – MedCore: Insulin pens are shaped like a writing pen, but have a reservoir for insulin and are used as a delivery method for insulin. To administer insulin, patients must remove the pen cap, clean the injection site with an alcohol swab, attach a pen needle, prime the pen, dial the appropriate dosage amount and finally inject the insulin. There is a dose dial on the side of the pen so the patient can choose the required dose.
  • US Market Report for Insulin Syringes 2019 – MedCore: Insulin is a protein and when administered orally, it degrades in the stomach and the intestines. When administered subcutaneously, it is better absorbed and has more of an effect on blood sugar levels. Although many alternative technologies have entered the insulin delivery device market, such as insulin pumps and insulin pens, syringes are still the most widely used device to inject insulin.
  • US Market Report for Insulin Pumps 2019 – MedCore: The total U.S. market for insulin pumps can be segmented by pump type, yielding three segments: traditional insulin pumps, patch insulin pumps and simple insulin pumps. In 2016, the largest segment in the total insulin pump market was the traditional pump segment, representing over 80% of the total market value. Traditional pumps account for such a large portion of the market because they are a much more established market, relative to the patch pump and simple pump markets, which were launched in the U.S. in 2005 and 2012, respectively. It is expected that traditional pumps will maintain their dominance over the forecast period, despite the growing market share of patch pumps and simple pumps.
  • OTHER INFORMATION – Company Profiles and SWOT, Disease Overviews, & Related Press Releases from Top Competitors

Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More

Diabetes Market Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2025, and Historical Data to 2015
  • Market Drivers & Limiters for Each Diabetes Device Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Diabetes Procedure Volumes
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors

Diabetes Market Share Analysis

In 2018, the vast majority of the overall market share was held by insulin manufacturers, Novo Nordisk, Eli Lilly and Sanofi. Novo Nordisk held the leading position in the ultra-long-acting insulin
rapid-acting insulin markets and the second-leading position in the long-acting insulin, premixed insulin and human insulin markets.

For a Full Table of Contents From Any of the Country Reports in this Global Series, please Contact iData

The "US Market Report for Diabetes Market Analysis, Size, Trends" includes analysis on the following companies currently active in this market:


All Companies Analyzed in this Study

  • Abbott
  • ACON Laboratories
  • AgaMatrix
  • Allison Medical
  • ApexBio
  • Arcadia Group
  • Ascensia
  • B. Braun
  • Becton Dickinson
  • Bionime
  • Biosense Medical Devices
  • Boehringer Ingelheim
  • CanAm
  • CVS
  • DarioHealth
  • Dexcom
  • Diabetic Supply of Suncoast
  • Eli Lilly
  • Excel International
  • Fifty 50 Medical
  • ForaCare
  • Genesis Health Technologies
  • Gluco Perfect
  • Home Aide Diagnostics
  • iHealth Labs
  • Infopia
  • Insulet
  • Intuity Medical
  • i-SENS
  • LifeScan
  • Livongo Health
  • McKesson
  • Medical Plastic Devices
  • MediPurpose
  • Medline
  • Medtronic
  • Nova Biomedical
  • Novo Nordisk
  • Oak Tree Health
  • Omnis Health
  • One Drop
  • Owen Mumford
  • Perrigo
  • Pharma Supply
  • Philosys
  • Platinum Equity
  • Playtex
  • Prodigy
  • Retractable Technologies
  • Roche
  • Sanofi
  • SD Biosensor
  • Senseonics
  • Simple Diagnostics
  • Smart Meter
  • Smiths Medical
  • Specialty Medical Supplies
  • STAT Medical Devices
  • Tandem
  • Telcare
  • Terumo
  • Trivia Health
  • U.S. Diagnostics
  • UltiMed
  • Unilife Medical Solutions
  • Valeritas
  • Vertex Diagnostics
  • Walmart
  • Ypsomed
For a Full Table of Contents From Any of the Country Reports in this Global Series, please Contact iData

For a Full Table of Contents From Any of the Country Reports in this Global Series, please Contact iData

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology